Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Hirohisa Yoshizawa
Observed names:
H Yoshizawa,
H. Yoshizawa,
HIROHISA YOSHIZAWA,
Hirohisa YOSHIZAWA,
Yoshizawa Hirohisa,
Yoshizawa, Hirohisa
show all 6
Institutions:
Niigata Cancer Center Hospital,
Niigata Medical Center,
Niigata University
Observed institutions:
University of Michigan,
Niigata Cancer Center Hospital,
Niigata University Medical and Dental Hospital,
Niigata Medical Center,
Niigata University
OpenAlex ID:
A5111441332
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
2010
·
Makoto Maemondo
, Akira Inoue
, et al.
·
New England Journal of Medicine
·
5,563
Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002)
2012
·
A. Inoue
, K. Kobayashi
, et al.
·
Annals of Oncology
·
544
Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial
2009
·
Mitsue Saito
, Kenjiro Aogi
, et al.
·
The Lancet Oncology
·
424
Clinical responses to EGFR-tyrosine kinase inhibitor retreatment in non-small cell lung cancer patients who benefited from prior effective gefitinib therapy: a retrospective analysis
2011
·
Satoshi Watanabe
, Junta Tanaka
, et al.
·
BMC Cancer
·
393
PDF
Eradication of established tumors in mice by a combination antibody-based therapy
2006
·
Tomoyasu Uno
, Kazuyoshi Takeda
, et al.
·
Nature Medicine
·
258
Specific adoptive immunotherapy mediated by tumor-draining lymph node cells sequentially activated with anti-CD3 and IL-2
1991
·
H Yoshizawa
, A E Chang
, et al.
·
The Journal of Immunology
·
211
Effectiveness of Gefitinib against Non–Small-Cell Lung Cancer with the Uncommon EGFR Mutations G719X and L861Q
2014
·
Satoshi Watanabe
, Yuji Minegishi
, et al.
·
Journal of Thoracic Oncology
·
206
PDF
Reciprocal CD4+ T-Cell Balance of Effector CD62Llow CD4+ and CD62LhighCD25+ CD4+ Regulatory T Cells in Small Cell Lung Cancer Reflects Disease Stage
2008
·
Kenichi Koyama
, Hiroshi Kagamu
, et al.
·
Clinical Cancer Research
·
136
Short-term use of continuous positive airway pressure ameliorates glomerular hyperfiltration in patients with obstructive sleep apnoea syndrome
2004
·
Shin-ichi KINEBUCHI
, Junichiro J. KAZAMA
, et al.
·
Clinical Science
·
131
Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomised, double-blind, placebo-controlled phase 3 trial
2012
·
H. Saito
, H. Yoshizawa
, et al.
·
Annals of Oncology
·
115
PDF
Randomized phase II study of concurrent versus sequential alternating gefitinib and chemotherapy in previously untreated non-small cell lung cancer with sensitive EGFR mutations: NEJ005/TCOG0902
2015
·
S. Sugawara
, S. Oizumi
, et al.
·
Annals of Oncology
·
110
Anti‐cytokine autoantibodies are ubiquitous in healthy individuals
2007
·
Masato Watanabe
, Kanji Uchida
, et al.
·
FEBS Letters
·
104
PDF
Quality of Life with Gefitinib in Patients with EGFR-Mutated Non-Small Cell Lung Cancer: Quality of Life Analysis of North East Japan Study Group 002 Trial
2012
·
Satoshi Oizumi
, Kunihiko Kobayashi
, et al.
·
The Oncologist
·
101
Both Regulatory T Cells and Antitumor Effector T Cells Are Primed in the Same Draining Lymph Nodes during Tumor Progression
2005
·
Toru Hiura
, Hiroshi Kagamu
, et al.
·
The Journal of Immunology
·
101
PDF
Daytime Hypoxemia, Sleep-Disordered Breathing, and Laryngopharyngeal Findings in Multiple System Atrophy
2007
·
Takayoshi Shimohata
, Hideo Shinoda
, et al.
·
Archives of Neurology
·
100
Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.
1993
·
A E Chang
, H Yoshizawa
, et al.
·
PubMed
·
88
Combination Therapy of Established Tumors by Antibodies Targeting Immune Activating and Suppressing Molecules
2010
·
Kazuyoshi Takeda
, Yuko Kojima
, et al.
·
The Journal of Immunology
·
85
Depletion of radio-resistant regulatory T cells enhances antitumor immunity during recovery from lymphopenia
2012
·
Junko Baba
, Satoshi Watanabe
, et al.
·
Blood
·
79
Activation by anti-CD3 of tumor-draining lymph node cells for specific adoptive immunotherapy
1991
·
Hirohisa Yoshizawa
, Keisuke Sakai
, et al.
·
Cellular Immunology
·
74
Efficacy and Safety of Long-Term Sirolimus Therapy for Asian Patients with Lymphangioleiomyomatosis
2016
·
Toshinori Takada
, Ayako Mikami
, et al.
·
Annals of the American Thoracic Society
·
63
Successful Adoptive Immunotherapy of Murine Poorly Immunogenic Tumor with Specific Effector Cells Generated from Gene-Modified Tumor-Primed Lymph Node Cells
1999
·
Hiroshi Tanaka
, Hirohisa Yoshizawa
, et al.
·
The Journal of Immunology
·
58
Cellular interactions in effector cell generation and tumor regression mediated by anti-CD3/interleukin 2-activated tumor-draining lymph node cells.
1992
·
H Yoshizawa
, A E Chang
, et al.
·
PubMed
·
55
Nephrotoxicity of cisplatin combination chemotherapy in thoracic malignancy patients with CKD risk factors
2016
·
Ko Sato
, Satoshi Watanabe
, et al.
·
BMC Cancer
·
54
PDF
Low-Dose Gefitinib Treatment for Patients with Advanced Non-small Cell Lung Cancer Harboring Sensitive Epidermal Growth Factor Receptor Mutations
2011
·
Hironori Satoh
, Akira Inoue
, et al.
·
Journal of Thoracic Oncology
·
53
Repressor of GATA regulates TH2-driven allergic airway inflammation and airway hyperresponsiveness
2008
·
Kiyoshi Hirahara
, Masakatsu Yamashita
, et al.
·
Journal of Allergy and Clinical Immunology
·
51
Show more works
View as search
Works count:
137
Citation count:
10,080
H-index:
32
I10-index:
57
Year
Topic
Type
